Active	Status	Sponsor type	Region	Phase	Filter
12 Active 1 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cornett, Karen
ARID II, NCT06873581: Pivotal Study of Voro Urologic Scaffold	Recruiting	3	266	US	Voro Urologic Scaffold	Levee Medical, Inc.	Radical Prostatectomy, Stress Urinary Incontinence (SUI)	02/27	02/27
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)	Recruiting	N/A	700	Europe, Japan, US, RoW	Prospective observational registry, Zolgensma	Novartis Pharmaceuticals, United BioSource, LLC	Spinal Muscular Atrophy (SMA)	06/38	06/38
Mazzarella, Brian
ARID II, NCT06873581: Pivotal Study of Voro Urologic Scaffold	Recruiting	3	266	US	Voro Urologic Scaffold	Levee Medical, Inc.	Radical Prostatectomy, Stress Urinary Incontinence (SUI)	02/27	02/27
PIVOT-006, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT	Recruiting	3	364	Canada, US	Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM	CG Oncology, Inc.	Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma	01/28	01/30
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27
BREEZE, NCT04987138: Safety and Effectiveness Study of the Zenflow Spring System	Active, not recruiting	N/A	279	US	Zenflow Spring System, Sham Procedure, Foley Catheter	Zenflow, Inc.	BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)	06/24	06/26
NCT05010759: Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer	Terminated	N/A	3	US	NanoTherm Ablation	MagForce USA	Prostate Cancer	07/23	07/23
NCT05186740: ProVee Urethral Expander System IDE Study (ProVIDE)	Active, not recruiting	N/A	221	Europe, Canada, US	ProVee Urethral Expander System, ProVee Expander, ProVee, Urethral Access Sheath	ProVerum Medical	Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms	03/24	12/28
NCT06236802: ProVIDE II Bridging Study	Active, not recruiting	N/A	40	Europe, US	ProVee device, ProVee Expander, ProVee	ProVerum Medical	BPH With Symptomatic Lower Urinary Tract Symptoms	09/24	06/29
CLEAR, NCT04338776: Comparing UroLift Experience Against Rezūm	Active, not recruiting	N/A	120	Europe, US	UroLift, Rezum	NeoTract, Inc.	Benign Prostatic Hyperplasia	05/25	12/25
WATER IV PCa, NCT06651632: WATER IV Prostate Cancer	Recruiting	N/A	280	Europe, Canada, US, RoW	Aquablation Therapy, Radical Prostatectomy	PROCEPT BioRobotics	Localized Prostate Cancer	07/27	01/37
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer	Active, not recruiting	N/A	400	US	Vanquish System	Francis Medical Inc.	Prostate Cancer	04/27	04/29

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cornett, Karen
ARID II, NCT06873581: Pivotal Study of Voro Urologic Scaffold	Recruiting	3	266	US	Voro Urologic Scaffold	Levee Medical, Inc.	Radical Prostatectomy, Stress Urinary Incontinence (SUI)	02/27	02/27
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)	Recruiting	N/A	700	Europe, Japan, US, RoW	Prospective observational registry, Zolgensma	Novartis Pharmaceuticals, United BioSource, LLC	Spinal Muscular Atrophy (SMA)	06/38	06/38
Mazzarella, Brian
ARID II, NCT06873581: Pivotal Study of Voro Urologic Scaffold	Recruiting	3	266	US	Voro Urologic Scaffold	Levee Medical, Inc.	Radical Prostatectomy, Stress Urinary Incontinence (SUI)	02/27	02/27
PIVOT-006, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT	Recruiting	3	364	Canada, US	Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM	CG Oncology, Inc.	Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma	01/28	01/30
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27
BREEZE, NCT04987138: Safety and Effectiveness Study of the Zenflow Spring System	Active, not recruiting	N/A	279	US	Zenflow Spring System, Sham Procedure, Foley Catheter	Zenflow, Inc.	BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)	06/24	06/26
NCT05010759: Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer	Terminated	N/A	3	US	NanoTherm Ablation	MagForce USA	Prostate Cancer	07/23	07/23
NCT05186740: ProVee Urethral Expander System IDE Study (ProVIDE)	Active, not recruiting	N/A	221	Europe, Canada, US	ProVee Urethral Expander System, ProVee Expander, ProVee, Urethral Access Sheath	ProVerum Medical	Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms	03/24	12/28
NCT06236802: ProVIDE II Bridging Study	Active, not recruiting	N/A	40	Europe, US	ProVee device, ProVee Expander, ProVee	ProVerum Medical	BPH With Symptomatic Lower Urinary Tract Symptoms	09/24	06/29
CLEAR, NCT04338776: Comparing UroLift Experience Against Rezūm	Active, not recruiting	N/A	120	Europe, US	UroLift, Rezum	NeoTract, Inc.	Benign Prostatic Hyperplasia	05/25	12/25
WATER IV PCa, NCT06651632: WATER IV Prostate Cancer	Recruiting	N/A	280	Europe, Canada, US, RoW	Aquablation Therapy, Radical Prostatectomy	PROCEPT BioRobotics	Localized Prostate Cancer	07/27	01/37
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer	Active, not recruiting	N/A	400	US	Vanquish System	Francis Medical Inc.	Prostate Cancer	04/27	04/29